WELLS FARGO & COMPANY/MN - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 41 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$106
-29.3%
1320.0%0.00%
Q2 2023$150
-20.2%
132
+5.6%
0.00%
Q1 2023$188
+2.7%
125
+1.6%
0.00%
Q4 2022$183123
+2.5%
0.00%
Q3 2022$0120
+96.7%
0.00%
Q2 2022$0
-100.0%
61
-99.1%
0.00%
Q1 2022$16,000
-68.6%
7,003
-20.3%
0.00%
Q4 2021$51,000
+5000.0%
8,783
+14298.4%
0.00%
Q3 2021$1,000
-99.1%
61
-99.4%
0.00%
Q2 2021$108,000
+208.6%
11,081
+365.6%
0.00%
Q1 2021$35,0002,3800.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$580,0000.02%
Virtu Financial LLC 15,980$93,0000.01%
Jump Financial, LLC 11,800$68,0000.00%
Investment Research & Advisory Group, Inc. 1,400$4,0000.00%
Cubist Systematic Strategies, LLC 12,804$74,0000.00%
UBS Group AG 22,402$130,0000.00%
RHUMBLINE ADVISERS 18,894$110,0000.00%
Ellevest, Inc. 18$00.00%
TWO SIGMA INVESTMENTS, LP 28,771$167,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,105$64,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders